期刊文献+

Roux-en-Y胃旁路术对2型糖尿病大鼠肝脏糖异生的影响 被引量:3

Influence of gastric bypass surgery on hepatic gluconeogenesis in type 2 diabetic Goto Kakizaki rats
原文传递
导出
摘要 目的探讨Roux-en-Y胃旁路术对2型糖尿病大鼠肝脏糖异生的影响及意义。方法将40只GotoKakizaki(GK)大鼠按随机数字表法分为Rollx-en-Y胃旁路术组(A组,20只)和假手术组(B组,20只)。分别于术前及术后1、2、4周行口服葡萄糖耐量实验(OGYr)。并记录体质量。于术前及术后第4周测定两组大鼠糖化血红蛋白(HbAlc)水平。术后第4周处死大鼠获取肝脏组织,采用反转录聚合酶链反应和Westernblot技术检测肝脏组织葡萄糖6磷酸酶(G-6-P)、磷酸烯醇式丙酮酸激酶(PEPCK)的mRNA及蛋白相对表达量。结果术后1、2、4周,A组大鼠平均空腹血糖分别为6.5、4.9和4.7mmol/L,而B组分别为10-3、10.4和12.5mmol/L。两组比较差异均有统计学意义(均P〈0.05);A组灌胃后2h血糖分别平均为8.3、6.4和5.5mmol/L,B组为21.4、23.8和24.7mmol/L,两组比较差异均有统计学意义(均P〈0.05)。A组术后第4周HbAlc为(6.8±1.0)%,低于B组的(7.9±0.8)%(P〈0.05)。A组术后4周肝脏G-6-P和PEPCK的mRNA相对表达较B组分别降低了21.0%和25.9%,蛋白表达水平也相应降低(均P〈0.05)。PAS染色示肝脏糖原沉积明显增多。结论Roux-en-Y胃旁路术后肝脏糖异生关键酶的mRNA相对表达和蛋白含量明显降低。肝脏糖异生减少.这可能是该术式的降糖机制之一。 Objective To investigate the influence and significance of gastric bypass surgery on hepatic gluconeogenesis in type 2 diabetic Goto Kakizaki (GK) rats. Methods Forty GK rats were randomly divided into Roux-en-Y gastric bypass group (group A) and sham operation group (group B). Differences in glucose tolerance experiment(OGTT) at preoperative and postoperative 1, 2 and 4 weeks were compared and weight was recorded. Glycated hemoglobin levels were measured preoperatively and 4 weeks postoperatively. The animals were sacrificed 4 weeks after surgery and liver tissues were harvested to detect the relative expression of mRNA and protein of glucose 6 phosphatase (G-6-P) and phosphoenol pyruvate kinase (PEPCK) with RT-PCR and Western blot. Results Fasting blood glucose levels were 6.5, 4.9, and 4.7 mmol/L in group A, and were 10.3, 10.4, and 12.5 mmol/L in group B, and the differences between two groups were statistically significant(P〈0.05). The blood glucose level at 2 h after stomach lavage were 8.3, 6.4 and 5.5 mmol/L in group A, and were 21.4, 23.8 and 24.7 mmol/L in group B at postoperative 1, 2, 4 weeks, and the differences between two groups were statistically significant(P〈0.05). The glycosylated hemoglobin at postoperative 4 weeks was(6.8±1.0)%, significantly lower than that in group B [(7.9±0.8)%, P〈0.05]. Hepatic G-6-P and PEPCK mRNA relative expression at postoperative 4 weeks was reduced by 21.0% and 25.9% respectively as compared to group B, and the protein expression reduced as well. Immunohistochemistry showed that hepaticglycogen sedimentary in group A increased significantly. Conclusion The relative mRNA and protein level of key enzymes of hepatic gluconeogenesis are significantly decreased after Roux-en-Y gastric bypass surgery and hepatic gluconeogenesis is reduced, which may be a potential mechanism of the decrease of blood glucose.
出处 《中华胃肠外科杂志》 CAS 2012年第11期1142-1145,共4页 Chinese Journal of Gastrointestinal Surgery
基金 全军临床高新技术重大项目(2010gxjs040)
关键词 ROUX-EN-Y胃旁路术 2型糖尿病 Goto Kakizaki大鼠 肝脏糖异生 Roux-en-Y gastric bypass Type 2 diabetes mellitus Goto-Kakizaki rat Hepatic gluconeogenesis
  • 相关文献

参考文献13

  • 1Moo TA, Rubino F. Gastrointestinal surgery as treatment for type 2 diabetes. Curt Opin Endocrinol Diabetes Obes, 2008, 15(2) : 153-158.
  • 2Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery, 2007,142(4) :621-635.
  • 3Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev, 2007,87(4) : 1409-1439.
  • 4伍松(综述),汤礼军(审校).糖原合酶激酶3与2型糖尿病的关系[J].西南军医,2011,12(5):911-913. 被引量:2
  • 5Kawano K, Hirashima T, Mori S, et al. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long- Evans Tokushima Fatty (OLETF) strain. Diabetes, 1992,41 ( 11 ) : 1422-1428.
  • 6杨景哥,王存川,胡友主,李进义,潘运龙,沈莹莹,黎泳欣,黄璟,俞春亮,刘贤明.腹腔镜Roux-en-Y胃旁路手术治疗肥胖症和2型糖尿病[J].中华胃肠外科杂志,2010,13(8):594-597. 被引量:15
  • 7陈涛,汤礼军,崔建峰,石力,胡睿东.Roux-en-Y胃转流术治疗2型糖尿病的近期疗效观察[J].西南国防医药,2009,19(10):1017-1018. 被引量:12
  • 8Meier JJ, Nauck MA, Schmidt WE, et al. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept, 2002,107(1-3) : 1-13.
  • 9Ring DB, Johnson KW, Henriksen EJ, et al. Selective glycogen synthase kinase-3 inhibitors potentiate insulin avtivation of glucose transport and utilization in vitro and vivo. Diabetes, 2003,52(3) :588-595.
  • 10DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc, 2008,22(3) :706-716.

二级参考文献34

  • 1PORIES W J,MACDONALD KGJR,FLICKINGER E G,et al. Is type II diabetes mellitus (NIDDM) a surgical disease [ J ]. Ann Surg, 1992,215 : 633 - 642.
  • 2WORLD HEALTH ORGANIZATION. Definition,diagnosis and classi - fication of diabetes mellitus and its complications. In:Report of a WHO Consultation[ M]. WHO/NCD/NCS/99.2. Geneva:WHO,1999.
  • 3DETOURNAY B, CROS S,CHARBONNEL B, et al. Managing type 2 diabetes in France: the ECODIA survey [ J ]. Diabetes Metab, 2000,26:363 - 369.
  • 4PORIES W J,SWANSON M S, MACDONALD K H,et al. Who would have thought it. An operation prove to be the most effective therapy for adult - onset diabetes mellitus [ J ]. Ann Surg,1995,222(3) :339 - 350.
  • 5RUBINO F, GAGNER M. Potential of surgery for curing type 2 diabetes mellitus [ J ]. Ann Surg,2002,236 ( 5 ) : 554 - 559.
  • 6RUBINO F,GAGNER M, GENTILESCHI P, et al. The early effect of the Roux - en - Y gastric bypass on hormones involved in body weight regulation and glucose metabolism [ J ]. Ann Surg,2004,240 (2) :236 - 242.
  • 7CLEMENTS R H,GONZALES Q H,LONG C L,et al. Homonal changes after Roux - en - Y gastric bypass for morbid obesity and the control of type 2 diabetes mellitus[ J]. Ann Surg,2004,70( 1 ) :1 - 5.
  • 8SMITH S C, GOODMAN G N,EDWARDS C B. Roux - en - Y gastric bypass. A 7 - year retrospective review of 3855 patients [ J ]. Obes Surg,1995 ,5 :314.
  • 9Livingston EH.Obe sity and its mrgical management.Am J surg,2002,184(2):103-113.
  • 10White S,Brooks E,Jurikova L,et al.Long-term outcomes after gastric bypass.Obes Surg,2005,15(2):155-163.

共引文献26

同被引文献11

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部